Errata (DOI:10.1016/j.cardfail.2004.11.004);Effect of valsartan on quality of life when added to usual therapy for heart failure: Results from the Valsartan Heart Failure Trial

Journal of Cardiac Failure

Volumn 11, Issue 4, 2005, Pages 253-259

  Majani, Giuseppina ^a   Giardini, Anna ^a   Opasich, Cristina ^a   Glazer, Robert ^b   Hester, Allen ^b   Tognoni, Gianni ^c   Cohn, Jay N ^d   Tavazzi, Luigi ^e  

^a IRCCS   (Italy)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF MINNESOTA   (United States)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Angiotensin receptor blocker; QOL; Val HeFT; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; VALSARTAN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

EID: 18144365472     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2005.05.009     Document Type: Erratum

References (19)

1. E.F. Lewis, P.A. Johnson, W. Johnson, C. Collins, L. Griffin, and L.W. Stevenson Preferences for quality of life or survival expressed by patients with heart failure J Heart Lung Transplant 20 2001 1016 1024
2. I.J. Higginson, and A.J. Carr Measuring quality of life: using quality of life measures in the clinical setting BMJ 322 2001 1297 1300
3. I. Cote, J.P. Gregoire, and J. Moisan Health-related quality-of-life measurement in hypertension. A review of randomized controlled drug trials Pharmacoeconomics 18 2000 435 450
4. T.S. Rector, L.K. Tschumperlin, S.H. Kubo, A.J. Bank, G.S. Francis, and K.M. McDonald Use of the Living with Heart Failure Questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death J Card Fail 1 1995 201 206
5. V. Konstam, D. Salem, H. Pouleur, J. Kostis, L. Gorkin, and S. Shumaker Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators Am J Cardiol 78 1996 890 895
6. S. Al-Kaade, and P.J. Hauptman Health-related quality of life measurement in heart failure: challenges for the new millennium J Card Fail 7 2001 194 201
7. J.N. Cohn, and G. Tognoni The effect of the angiotensin receptor blocker valsartan on morbidity and mortality in heart failure N Engl J Med 345 2001 1667 1675
8. H. Ni, W. Toy, D. Burgess, K. Wise, D.J. Nauman, and K. Crispell Comparative responsiveness of Short-Form 12 and Minnesota Living With Heart Failure Questionnaire in patients with heart failure J Card Fail 6 2000 83 91
9. T.S. Rector, and J.N. Cohn Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group Am Heart J 124 1992 1017 1025
10. T.S. Rector, S.H. Kubo, and J.N. Cohn Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo Am J Cardiol 71 1993 1106 1107
11. J.N. Cohn, G. Tognoni, R. Glazer, and D. Spormann Baseline demographics of the Valsartan Heart Failure Trial. Val-HeFT Investigators Eur J Heart Fail 2 2000 439 446
12. J.N. Cohn, and G.S. Francis Cardiac failure: a revised paradigm J Card Fail 4 1995 261 266
13. M. Wong, L. Staszewsky, R. Latini, S. Barlera, A. Volpi, and Y.T. Chiang Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study J Am Coll Cardiol 40 2002 970 975
14. R. Latini, S. Masson, I. Anand, D. Judd, A. Maggioni, and Y.T. Chiang Effect of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure Circulation 106 2002 2454 2458
15. T.A. Murberg, E. Bru, T. Aarsland, and S. Svebak Functional status and depression among men and women with congestive heart failure Int J Psychiatry Med 28 1998 273 291
16. J.C. Coyne, M.J. Rohrbaugh, V. Shoham, J.S. Sonnega, J.M. Nicklas, and J.A. Cranford Prognostic importance of marital quality for survival of congestive heart failure Am J Cardiol 88 2001 526 529
17. M.S. Riedinger, K.A. Dracup, M.L. Brecht, G. Padilla, L. Sarna, and P.A. Ganz Quality of life in patients with heart failure: do gender differences exist? Heart Lung 30 2001 105 116
18. P.E. Carson, and J.N. Cohn Effect of valsartan on time-adjusted and hospitalization frequency rate in the Valsartan Heart Failure Trial J Am Coll Cardiol 39 Suppl 1 2002 168A
19. G.L. Albrecht, and P.J. Devlieger The disability paradox: high quality of life against all odds Soc Sci Med 48 1999 977 988